ALLISON RABE: Open Payments
NPI 1376048140 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 41 payments from 13 companies in 2025. Trend: 2023 $858 · 2024 $1,054 · 2025 $1,011
Food & beverage: $840Education: $171
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $245 |
| GENZYME CORPORATION | 6 | $174 |
| ABBVIE INC. | 9 | $143 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $98 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| Lilly USA, LLC | 3 | $57 |
| UCB, Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $21 |
Products named: DUPIXENT, TREMFYA, Winlevi, SKYRIZI, RINVOQ, TALTZ, LIBTAYO, Bimzelx.
Industry payments across DE — which companies pay providers there.
